Try our Advanced Search for more refined results

November 29, 2022

Janssen Biotech, Inc. v. Amgen Inc.

Track this case

Case Number:

1:22-cv-01549

Court:

Delaware

Nature of Suit:

Patent

Judge:

Maryellen Noreika

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 23, 2023

    Janssen And Amgen Settle Patent Row Over Stelara Biosimilar

    Janssen and Amgen told a Delaware federal judge Monday they've agreed to settle a dispute over Janssen's attempt to block Amgen from launching a copycat version of its blockbuster immunosuppressive product Stelara, which treats conditions like ulcerative colitis and Crohn's disease, according to a notice filed Monday.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!